Screener
TG Therapeutics TGTX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's net income?
- TG Therapeutics (TGTX) reported net income of $7.78M in Q2 2026.
- How has TG Therapeutics's net income changed year-over-year?
- TG Therapeutics's net income decreased by 72.4% year-over-year, from $28.19M to $7.78M.
- What is the long-term trend for TG Therapeutics's net income?
- Over 3 years (2021 to 2025), TG Therapeutics's net income has grown at a 8.7% compound annual growth rate (CAGR), from -$348.1M to $447.18M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about TG Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude